Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity.

Vella, S; Galluzzo, C; Giannini, G; Pirillo, M F; Duncan, I; Jacobsen, H; Andreoni, M; Sarmati, L; Ercoli, L

Vella, S; Galluzzo, C; Giannini, G; Pirillo, M F; Duncan, I; Jacobsen, H; Andreoni, M; Sarmati, L; Ercoli, L.

Affiliation

Vella S; Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy.

Antiviral Res ; 29(1): 91-3, 1996 Jan.

Article in En | MEDLINE | ID: mdl-8721555

Subject(s)

Antiviral Agents/therapeutic use; HIV Infections/drug therapy; HIV Protease Inhibitors/therapeutic use; Isoquinolines/therapeutic use; Quinolines/therapeutic use; Zidovudine/therapeutic use; CD4 Lymphocyte Count; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Isoquinolines/adverse effects; Quinolines/adverse effects; RNA, Viral/blood; Saquinavir; Zidovudine/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Quinolines / Zidovudine / HIV Infections / HIV Protease Inhibitors / Isoquinolines Type of study: Clinical_trials / Diagnostic_studies Limits: Humans Language: En Journal: Antiviral Res Year: 1996 Document type: Article Affiliation country: Italy Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links